KRISTIE BURT: Open Payments
NPI 1073887659 · LEESBURG, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 60 payments from 16 companies in 2025. Trend: 2023 $1,297 · 2024 $1,257 · 2025 $1,107
Food & beverage: $938Education: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $246 |
| Astellas Pharma US Inc | 5 | $212 |
| AstraZeneca Pharmaceuticals LP | 8 | $193 |
| PFIZER INC. | 5 | $88 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Lundbeck LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Atland Pharmaceuticals, LLC | 1 | $32 |
| Amgen Inc. | 2 | $30 |
Products named: AIRSUPRA, VRAYLAR, NURTEC ODT, LEQVIO, CAPLYTA, Veozah, REXULTI, Kerendia.
Industry payments across AL — which companies pay providers there.
